Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J Invasive Cardiol ; 18(8): 376-81, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16877787

ABSTRACT

BACKGROUND: Myocardial infarction with normal coronary arteries (MINCA) is a well-documented syndrome often associated with global left ventricular wall motion abnormalities (LVWMAs). Recent literature has emphasized the occurrence of Takotsubo cardiomyopathy associated with MINCA. What has not been reported is the incidence of MINCA in the general population and the relative frequency of other types of associated LVWMAs. METHODS AND RESULTS: Data were retrospectively collected on 165 consecutive patients with ST-elevation myocardial infarction (STEMI) and 244 patients with non-ST-elevation myocardial infarction (NSTEMI) who underwent cardiac catheterization at a single institution in Marin County, California. Thirty-two of the 409 (7.8%) patients had MINCA. Of the patients presenting with STEMI, 10.3% had MINCA, and 6.1% of the patients presenting with NSTEMI had MINCA. Females were more likely to present with MINCA than males, both for STEMI (21.6% vs. 5.3%; p < 0.001) and NSTEMI (12.1% vs. 2.6%; p < 0.001). Of the 32 patients who presented with MINCA, 7 (21.9%) females had Takotsubo cardiomyopathy, while 10 (31.3%) patients (9 females, 1 male) had other previously undescribed focal anterior and inferior LVWMAs. A recent stressful event was noted in 50% (47.8% of females, 55.6% of males) of the patients with MINCA. CONCLUSIONS: An unexpectedly high incidence of MINCA with newly-described focal anterior and inferior LVWMAs as well as Takotsubo cardiomyopathy was observed in our community hospital. This syndrome occurred predominantly in females and was often associated with a recent stressful event. As these results were from a community, rather than a referral hospital, this finding challenges the current thought about the incidence of this syndrome in the general population.


Subject(s)
Coronary Angiography , Myocardial Infarction/complications , Ventricular Dysfunction, Left/complications , Ventricular Dysfunction, Left/epidemiology , Adult , Aged , Aged, 80 and over , Biomarkers/blood , Echocardiography , Electrocardiography , Female , Follow-Up Studies , Hospitals, Community , Humans , Incidence , Male , Middle Aged , Myocardial Infarction/blood , Myocardial Infarction/diagnosis , Retrospective Studies , Ventricular Dysfunction, Left/blood , Ventricular Dysfunction, Left/diagnosis
2.
J Cardiovasc Electrophysiol ; 16(6): 576-81, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15946352

ABSTRACT

UNLABELLED: Thromboembolic events are important complications of pulmonary vein isolation (PVI) procedures, occurring in up to 2.8% of patients. In this study, we report the incidence of char formation and embolic events with different anticoagulation protocols prospectively changed to reduce such complication. METHODS: A total of 785 patients (mean age: 54 years, 83.5% male) underwent catheter-based PVI for treatment of drug refractory, symptomatic atrial fibrillation (AF). PVI was performed utilizing different strategies including radiofrequency (RF) using temperature control energy delivery and RF using intracardiac echocardiography (ICE)-guided power titration. Patients were divided based on the anticoagulation protocol into three groups: in group 1 (194 patients), activation coagulation time (ACT) was maintained between 250 and 300 seconds; in group 2 (180 patients), ACT was maintained between 300 and 350 seconds plus the IV infusion of eptifibatide (135 microg/kg bolus + 0.5 microg/kg/min); and in group 3 (411 patients), ACT was maintained between 350 and 400 seconds. RESULTS: Char formation was detected in 69 patients of group 1, 5 of group 2, and 8 of group 3. An embolic event was observed in 7 patients of group 1, 3 of group 2, and 2 of group 3 (P = 0.01; group 1 vs group 3). Higher degree of anticoagulation with heparin was associated with a reduced incidence of embolic events even after removing the patients undergoing ICE-guided ablation (P = 0.04). CONCLUSION: More aggressive anticoagulation with heparin reduced periprocedural embolic events. The use of platelet inhibition does not have incremental beneficial effect. None of the anticoagulation protocol abolished char formation.


Subject(s)
Anticoagulants/therapeutic use , Atrial Fibrillation/surgery , Catheter Ablation/methods , Heparin/therapeutic use , Intraoperative Complications/prevention & control , Pulmonary Veins/physiopathology , Thromboembolism/prevention & control , Atrial Fibrillation/diagnostic imaging , Catheter Ablation/adverse effects , Clinical Protocols , Echocardiography, Transesophageal , Female , Humans , Intraoperative Complications/diagnostic imaging , Jugular Veins/surgery , Male , Middle Aged , Prospective Studies , Risk Factors , Thromboembolism/diagnostic imaging , Thromboembolism/etiology
3.
J Cardiovasc Electrophysiol ; 15(7): 784-9, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15250863

ABSTRACT

INTRODUCTION: Sick sinus syndrome is commonly associated with tachyarrhythmias and bradyarrhythmias that often are symptomatic. The aim of this study was to assess the effect of pulmonary vein isolation in patients with sick sinus syndrome and atrial fibrillation (AF). METHODS AND RESULTS: Three hundred fourteen consecutive patients who underwent pulmonary vein isolation between December 2000 and January 2002 were included in the study. Thirty-one patients had sick sinus syndrome, which was defined as a preprocedural history of symptomatic sinus bradycardia or pauses. Endpoints included AF recurrence, change in the frequency of sinus pauses, and symptoms of presyncope or syncope, as well as mean heart rate and percentage of atrial pacing in patients with pacemakers implanted prior to the pulmonary vein isolation. Patients had AF for an average of 6 +/- 3 years. Patients were 58 +/-8 years old and had ejection fractions of 55 +/- 4%. Sixty-one percent had implanted pacemakers. AF recurred within 6 months in 4 patients. Two had a successful second pulmonary vein isolation procedure. There were no recurrences of presyncopal events (P < 0.05) or documented sinus pauses (P < 0.05) after successful pulmonary vein isolation in the patients without permanent pacemakers. Patients with pacemakers had a 13-fold reduction in the percentage of atrial pacing (P < 0.05). Both groups showed a significant increase in average heart rates at 6-month follow-up. CONCLUSION: Cure of AF by pulmonary vein isolation helped resolve the clinical manifestations of sick sinus syndrome, suggesting that the occurrence of AF and/or the associated treatment could be partially responsible for sick sinus syndrome.


Subject(s)
Atrial Fibrillation/surgery , Pacemaker, Artificial , Pulmonary Veins , Sick Sinus Syndrome/surgery , Analysis of Variance , Atrial Fibrillation/etiology , Atrial Fibrillation/physiopathology , Catheter Ablation , Chi-Square Distribution , Electrocardiography , Female , Humans , Male , Middle Aged , Recurrence , Sick Sinus Syndrome/complications , Sick Sinus Syndrome/physiopathology , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...